NORWICH CLINICAL SERVICES PRIVATE LIMITED

Bengaluru-based Norwich Clinical Services generated a revenue figure of Rs 54 crore during the FY19-20, exhibiting a growth of 32 per cent when compared to the revenue generation of Rs 41 crore during the FY18

19. Norwich has state–of-the-art facilities, and exceptional expertise to conduct Phase I, II and III studies, bioavailability and bioequivalence studies, pharmacokinetic studies in patients & healthy subjects, drug metabolism studies, dose proportionality studies, multiple-dose studies and clinical developmental programmes. Its team has considerable experience in various dosage forms including parenterals, suspensions, topical preparations and delayed-release formulations.